Chris Rice
Impact in
- Immunology top 5%
- Immune cells in cancer
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
- Nephrology top 10%
- Dialysis and Renal Disease Management
Papers in
-
- Immune cells in cancer 4
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 4
- Phagocytosis and Immune Regulation 1
-
- COVID-19 Clinical Research Studies 2
- Co-authors
- Luke C. Davies (4 shared papers)Daniel W. McVicar (4 shared papers)Erika Mariana Palmieri (3 shared papers)Tracey Ann Rouault (2 shared papers)Nunziata Maio (2 shared papers)Marieli Gonzalez-Cotto (2 shared papers)Jonathan M. Weiss (2 shared papers)David A. Wink (1 shared paper)
- Journals
- Nature Communications (3 papers)Life Science Alliance (1 paper)Journal of Leukocyte Biology (1 paper)eLife (1 paper)EMBO Reports (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Chris Rice
12 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 87
- Immunology 433
- Nephrology 72
- Cancer Research 94
- Oncology 115
- Biochemistry 27
Countries citing papers authored by Chris Rice
This map shows the geographic impact of Chris Rice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Rice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Rice more than expected).
Fields of papers citing papers by Chris Rice
This network shows the impact of papers produced by Chris Rice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Rice. The network helps show where Chris Rice may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris Rice, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 374 | |
| 2 | 2014 | 314 | |
| 3 | 2018 | 284 | |
| 4 | 2017 | 83 | |
| 5 | 2018 | 46 | |
| 6 | 2020 | 37 | |
| 7 | 2022 | 25 | |
| 8 | 2021 | 15 | |
| 9 | 2024 | 6 | |
| 10 | 2025 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2026 | 1 |
About Chris Rice
Chris Rice is a scholar working on Immunology, Infectious Diseases, Oncology, Genetics and Neurology, having authored 12 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), COVID-19 Clinical Research Studies (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Blood disorders and treatments (2 papers), Phagocytosis and Immune Regulation (1 paper), Inflammasome and immune disorders (1 paper) and Cardiac Fibrosis and Remodeling (1 paper). The work is most often cited by research in Immunology (433 citations), Nephrology (72 citations), Cancer Research (94 citations), Oncology (115 citations) and Biochemistry (27 citations). Chris Rice has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Luke C. Davies, Daniel W. McVicar, Erika Mariana Palmieri, Tracey Ann Rouault, Nunziata Maio, Marieli Gonzalez-Cotto, Jonathan M. Weiss, David A. Wink, Andrew N. Lane and Richard M. Higashi. Their work appears in journals such as Nature Communications, Life Science Alliance, Journal of Leukocyte Biology, eLife and EMBO Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.